17q11.2 microduplication syndrome

17q11.2 microduplication syndrome is a rare chromosomal disorder caused by a duplication of a small segment of the long arm of chromosome 17 at band 11.2. This region encompasses the NF1 gene and surrounding genes. The duplication is considered the reciprocal event of the 17q11.2 microdeletion that causes neurofibromatosis type 1 (NF1) deletion syndrome. The condition is also referred to as NF1 microduplication syndrome or 17q11.2 duplication syndrome. The syndrome primarily affects neurodevelopmental and musculoskeletal systems. Key clinical features include mild to moderate intellectual disability, learning difficulties, developmental delay (particularly speech and language delay), and behavioral problems. Some individuals may exhibit dysmorphic facial features, which can include a broad or prominent forehead, hypertelorism, and a flat nasal bridge. Congenital heart defects, short stature, and hypotonia have also been reported in some cases. The clinical presentation is highly variable, and some carriers of the duplication may be mildly affected or even asymptomatic, which can complicate diagnosis and genetic counseling. There is no specific cure or targeted treatment for 17q11.2 microduplication syndrome. Management is supportive and symptom-based, typically involving early intervention programs, speech therapy, occupational therapy, special educational support, and behavioral therapy as needed. Cardiac anomalies, if present, are managed according to standard clinical protocols. Regular developmental monitoring is recommended. Genetic counseling is important for affected families, as the duplication can be inherited from a mildly affected or apparently unaffected parent.

Common questions about 17q11.2 microduplication syndrome